COVID-19 Vaccine Considerations for Appendix Cancer and Pseudomyxoma Peritonei Patients
February 8, 2021
For more information regarding COVID-19 recommendations and resources for appendix cancer and pseudomyxoma peritonei patients go to our other pages: COVID-19 Patient Information and/or COVID-19 Resources General considerations: Two vaccines are currently being distributed in the United States through Emergency Use Authorization (EUA): the BNT162b2 (Pfizer) and mRNA-1273 (Moderna) mRNA COVID-19 vaccines. Both vaccines achieved 94-95% vaccine efficacy in the...